| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cell Cycle Proteins | 23 | 2025 | 699 | 5.090 |
Why?
|
| Chromosomal Proteins, Non-Histone | 13 | 2025 | 210 | 4.090 |
Why?
|
| Separase | 11 | 2020 | 28 | 3.050 |
Why?
|
| Chromatids | 11 | 2024 | 32 | 2.250 |
Why?
|
| Nuclear Proteins | 10 | 2021 | 1219 | 1.530 |
Why?
|
| Endopeptidases | 6 | 2011 | 107 | 1.520 |
Why?
|
| Neoplasms | 8 | 2024 | 2959 | 1.510 |
Why?
|
| Aneuploidy | 8 | 2024 | 139 | 1.470 |
Why?
|
| DNA Repair | 4 | 2021 | 580 | 1.150 |
Why?
|
| DNA-Binding Proteins | 10 | 2025 | 1958 | 1.050 |
Why?
|
| Phosphoproteins | 7 | 2019 | 434 | 1.040 |
Why?
|
| Gonadotropin-Releasing Hormone | 11 | 2002 | 71 | 1.000 |
Why?
|
| Protein Subunits | 3 | 2015 | 160 | 0.880 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2015 | 626 | 0.860 |
Why?
|
| De Lange Syndrome | 2 | 2021 | 44 | 0.850 |
Why?
|
| Chromosome Segregation | 5 | 2024 | 68 | 0.810 |
Why?
|
| Benzimidazoles | 3 | 2020 | 154 | 0.760 |
Why?
|
| Hematopoiesis | 4 | 2023 | 214 | 0.680 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2020 | 34 | 0.630 |
Why?
|
| Goldfish | 6 | 2002 | 8 | 0.630 |
Why?
|
| Antineoplastic Agents | 4 | 2019 | 1803 | 0.620 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2013 | 236 | 0.620 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2021 | 263 | 0.600 |
Why?
|
| Oocytes | 7 | 2007 | 274 | 0.520 |
Why?
|
| Apoptosis | 5 | 2020 | 1860 | 0.520 |
Why?
|
| Ovarian Follicle | 7 | 2002 | 123 | 0.490 |
Why?
|
| Ovary | 9 | 2007 | 358 | 0.490 |
Why?
|
| Animals | 32 | 2025 | 33954 | 0.480 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2017 | 240 | 0.470 |
Why?
|
| Sister Chromatid Exchange | 2 | 2021 | 15 | 0.470 |
Why?
|
| Body Weight | 1 | 2019 | 990 | 0.460 |
Why?
|
| Leukemia | 4 | 2011 | 374 | 0.450 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2011 | 734 | 0.450 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2023 | 1266 | 0.440 |
Why?
|
| Antigens, Nuclear | 2 | 2019 | 52 | 0.430 |
Why?
|
| HeLa Cells | 5 | 2015 | 688 | 0.400 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2024 | 609 | 0.390 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2017 | 2028 | 0.350 |
Why?
|
| Meiosis | 7 | 2020 | 112 | 0.350 |
Why?
|
| Transcription Factors | 1 | 2021 | 2452 | 0.350 |
Why?
|
| Calpain | 1 | 2011 | 43 | 0.350 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2012 | 595 | 0.340 |
Why?
|
| Receptors, LHRH | 6 | 2002 | 13 | 0.340 |
Why?
|
| Lymphoma, T-Cell | 1 | 2011 | 64 | 0.330 |
Why?
|
| Amino Acid Sequence | 7 | 2015 | 2401 | 0.330 |
Why?
|
| Adenocarcinoma | 2 | 2015 | 996 | 0.310 |
Why?
|
| Lymphoma, B-Cell | 1 | 2011 | 149 | 0.310 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2009 | 77 | 0.300 |
Why?
|
| Molecular Sequence Data | 6 | 2015 | 3498 | 0.290 |
Why?
|
| Oligopeptides | 1 | 2009 | 106 | 0.290 |
Why?
|
| Mice | 12 | 2025 | 18235 | 0.290 |
Why?
|
| DNA Damage | 3 | 2021 | 522 | 0.280 |
Why?
|
| Chromosomal Instability | 2 | 2008 | 58 | 0.280 |
Why?
|
| Multiprotein Complexes | 1 | 2008 | 194 | 0.270 |
Why?
|
| Protein Structure, Secondary | 2 | 2021 | 238 | 0.260 |
Why?
|
| Humans | 31 | 2024 | 130921 | 0.260 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2020 | 1143 | 0.250 |
Why?
|
| Models, Biological | 2 | 2009 | 1392 | 0.250 |
Why?
|
| Binding Sites | 5 | 2013 | 1147 | 0.250 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2025 | 579 | 0.250 |
Why?
|
| Structure-Activity Relationship | 4 | 2016 | 554 | 0.240 |
Why?
|
| Cell Line, Tumor | 8 | 2022 | 3711 | 0.240 |
Why?
|
| Enzyme Inhibitors | 4 | 2016 | 565 | 0.240 |
Why?
|
| Myosin Heavy Chains | 1 | 2025 | 75 | 0.230 |
Why?
|
| Disease Progression | 1 | 2011 | 2206 | 0.220 |
Why?
|
| Metaphase | 3 | 2009 | 31 | 0.210 |
Why?
|
| Protein Binding | 3 | 2015 | 1666 | 0.210 |
Why?
|
| Blotting, Western | 3 | 2013 | 1014 | 0.210 |
Why?
|
| Maturation-Promoting Factor | 2 | 2000 | 9 | 0.210 |
Why?
|
| Haploinsufficiency | 1 | 2025 | 262 | 0.210 |
Why?
|
| Oncogenes | 3 | 2017 | 164 | 0.210 |
Why?
|
| Nuclear Receptor Co-Repressor 1 | 1 | 2023 | 51 | 0.200 |
Why?
|
| Peptides | 4 | 2014 | 711 | 0.200 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2025 | 244 | 0.200 |
Why?
|
| Testosterone | 4 | 2002 | 599 | 0.190 |
Why?
|
| Progesterone | 2 | 2004 | 441 | 0.190 |
Why?
|
| Genomic Instability | 1 | 2024 | 246 | 0.180 |
Why?
|
| Amino Acid Motifs | 2 | 2013 | 194 | 0.180 |
Why?
|
| Protein Kinases | 2 | 2000 | 317 | 0.180 |
Why?
|
| Fungal Proteins | 1 | 2002 | 131 | 0.180 |
Why?
|
| Breast Neoplasms | 3 | 2014 | 2652 | 0.180 |
Why?
|
| Arachidonic Acid | 1 | 2002 | 54 | 0.180 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2013 | 752 | 0.180 |
Why?
|
| Female | 23 | 2020 | 70722 | 0.180 |
Why?
|
| CDC2 Protein Kinase | 2 | 2012 | 36 | 0.180 |
Why?
|
| Estrogens | 1 | 2004 | 433 | 0.180 |
Why?
|
| Protein Kinase C | 1 | 2002 | 113 | 0.180 |
Why?
|
| Mammary Glands, Animal | 1 | 2004 | 447 | 0.170 |
Why?
|
| Carcinogenesis | 1 | 2024 | 352 | 0.170 |
Why?
|
| Immunoprecipitation | 2 | 2013 | 190 | 0.170 |
Why?
|
| Sarcoma, Ewing | 1 | 2022 | 117 | 0.170 |
Why?
|
| Two-Hybrid System Techniques | 2 | 2012 | 60 | 0.160 |
Why?
|
| Biomarkers, Tumor | 1 | 2009 | 1622 | 0.160 |
Why?
|
| Conserved Sequence | 1 | 2021 | 280 | 0.160 |
Why?
|
| Intestinal Pseudo-Obstruction | 1 | 2020 | 30 | 0.160 |
Why?
|
| Drug Stability | 1 | 2020 | 56 | 0.160 |
Why?
|
| Cell Proliferation | 3 | 2014 | 2476 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 2 | 2023 | 4707 | 0.160 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2020 | 141 | 0.150 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2023 | 548 | 0.150 |
Why?
|
| Anaphase | 2 | 2009 | 13 | 0.150 |
Why?
|
| DNA Replication | 1 | 2021 | 357 | 0.150 |
Why?
|
| Steroids | 1 | 2000 | 170 | 0.150 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2021 | 403 | 0.140 |
Why?
|
| Aminopyridines | 1 | 2019 | 63 | 0.140 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2019 | 94 | 0.140 |
Why?
|
| Purines | 1 | 2019 | 115 | 0.140 |
Why?
|
| Models, Molecular | 1 | 2021 | 1059 | 0.140 |
Why?
|
| Models, Animal | 1 | 2019 | 459 | 0.130 |
Why?
|
| Eosinophilia | 1 | 2019 | 107 | 0.130 |
Why?
|
| Cell Survival | 1 | 2020 | 845 | 0.130 |
Why?
|
| Mitosis | 2 | 2011 | 186 | 0.130 |
Why?
|
| Metallothionein | 1 | 1996 | 16 | 0.130 |
Why?
|
| Gene Expression | 1 | 2021 | 1494 | 0.130 |
Why?
|
| Neoplasm Transplantation | 2 | 2015 | 360 | 0.120 |
Why?
|
| Zinc | 1 | 1996 | 128 | 0.120 |
Why?
|
| Cell Differentiation | 1 | 2023 | 1930 | 0.120 |
Why?
|
| Barrett Esophagus | 1 | 2020 | 359 | 0.120 |
Why?
|
| Maximum Tolerated Dose | 2 | 2014 | 173 | 0.120 |
Why?
|
| Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase | 1 | 2015 | 6 | 0.110 |
Why?
|
| Kinetics | 4 | 2009 | 1090 | 0.110 |
Why?
|
| Cells, Cultured | 3 | 2015 | 2916 | 0.110 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 1995 | 65 | 0.110 |
Why?
|
| ErbB Receptors | 1 | 1996 | 297 | 0.110 |
Why?
|
| Base Sequence | 2 | 2011 | 2757 | 0.110 |
Why?
|
| Rhodamines | 1 | 2014 | 22 | 0.110 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2014 | 85 | 0.100 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 619 | 0.100 |
Why?
|
| Hydrolysis | 1 | 2014 | 140 | 0.100 |
Why?
|
| Sf9 Cells | 1 | 2013 | 10 | 0.100 |
Why?
|
| Spodoptera | 1 | 2013 | 28 | 0.100 |
Why?
|
| Rats | 1 | 2020 | 3434 | 0.100 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 2013 | 99 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 376 | 0.100 |
Why?
|
| Collagen | 1 | 2015 | 287 | 0.100 |
Why?
|
| Mice, Knockout | 1 | 2021 | 3840 | 0.100 |
Why?
|
| Protein Interaction Mapping | 1 | 2013 | 90 | 0.100 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 414 | 0.100 |
Why?
|
| Mutant Proteins | 1 | 2013 | 110 | 0.100 |
Why?
|
| High-Throughput Screening Assays | 1 | 2014 | 115 | 0.100 |
Why?
|
| Protein Stability | 1 | 2013 | 166 | 0.100 |
Why?
|
| Binding, Competitive | 5 | 1997 | 147 | 0.100 |
Why?
|
| Mutation | 4 | 2022 | 6153 | 0.100 |
Why?
|
| Microscopy, Fluorescence | 1 | 2014 | 305 | 0.090 |
Why?
|
| Antibodies | 1 | 2014 | 320 | 0.090 |
Why?
|
| RNA, Messenger | 2 | 2008 | 2568 | 0.090 |
Why?
|
| Sequence Deletion | 1 | 2015 | 519 | 0.090 |
Why?
|
| Disease Models, Animal | 3 | 2025 | 4665 | 0.090 |
Why?
|
| Protein Multimerization | 1 | 2013 | 149 | 0.090 |
Why?
|
| Carps | 1 | 1992 | 4 | 0.090 |
Why?
|
| Epithelial Cells | 2 | 2008 | 902 | 0.090 |
Why?
|
| S Phase | 1 | 2012 | 73 | 0.090 |
Why?
|
| Prophase | 1 | 2011 | 3 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2012 | 105 | 0.090 |
Why?
|
| Osmolar Concentration | 4 | 1997 | 148 | 0.090 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2013 | 570 | 0.090 |
Why?
|
| Cyclin B | 1 | 2011 | 22 | 0.090 |
Why?
|
| Mice, Transgenic | 2 | 2015 | 2340 | 0.090 |
Why?
|
| Jurkat Cells | 1 | 2011 | 85 | 0.090 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2013 | 380 | 0.090 |
Why?
|
| Cell Nucleus | 1 | 2013 | 564 | 0.090 |
Why?
|
| Thymus Neoplasms | 1 | 2011 | 40 | 0.080 |
Why?
|
| Substrate Specificity | 1 | 2011 | 286 | 0.080 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2013 | 599 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2011 | 619 | 0.080 |
Why?
|
| Estrogen Receptor alpha | 1 | 2013 | 433 | 0.080 |
Why?
|
| Amino Acid Substitution | 1 | 2011 | 409 | 0.080 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 1605 | 0.080 |
Why?
|
| Recombinant Proteins | 1 | 2013 | 1318 | 0.080 |
Why?
|
| Longevity | 1 | 2011 | 176 | 0.080 |
Why?
|
| Cell Cycle | 1 | 2012 | 597 | 0.080 |
Why?
|
| O(6)-Methylguanine-DNA Methyltransferase | 1 | 2009 | 19 | 0.080 |
Why?
|
| Bone Marrow | 1 | 2011 | 314 | 0.080 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2009 | 41 | 0.080 |
Why?
|
| Enzyme Stability | 1 | 2009 | 58 | 0.080 |
Why?
|
| RNA, Small Interfering | 1 | 2011 | 658 | 0.070 |
Why?
|
| Dacarbazine | 1 | 2009 | 94 | 0.070 |
Why?
|
| Xenopus laevis | 1 | 2009 | 122 | 0.070 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2015 | 757 | 0.070 |
Why?
|
| Chromatin | 1 | 2012 | 501 | 0.070 |
Why?
|
| Tissue Array Analysis | 1 | 2009 | 135 | 0.070 |
Why?
|
| Genetic Complementation Test | 1 | 2008 | 87 | 0.070 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2009 | 97 | 0.070 |
Why?
|
| Macromolecular Substances | 1 | 2009 | 131 | 0.070 |
Why?
|
| HEK293 Cells | 1 | 2011 | 805 | 0.070 |
Why?
|
| Models, Statistical | 1 | 2011 | 486 | 0.070 |
Why?
|
| Neoplasm Metastasis | 1 | 2011 | 708 | 0.070 |
Why?
|
| Cell Line | 2 | 2013 | 2573 | 0.070 |
Why?
|
| Luminescent Proteins | 1 | 2008 | 142 | 0.070 |
Why?
|
| Tetracycline | 1 | 2008 | 75 | 0.070 |
Why?
|
| Enzyme Activation | 1 | 2009 | 587 | 0.070 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2008 | 296 | 0.070 |
Why?
|
| Phosphorylation | 1 | 2011 | 1568 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2008 | 138 | 0.070 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 1388 | 0.070 |
Why?
|
| Gene Amplification | 1 | 2008 | 227 | 0.070 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1996 | 1008 | 0.070 |
Why?
|
| Meiotic Prophase I | 1 | 2007 | 1 | 0.070 |
Why?
|
| Rad51 Recombinase | 1 | 2007 | 32 | 0.060 |
Why?
|
| Male | 7 | 2020 | 64807 | 0.060 |
Why?
|
| Carrier Proteins | 1 | 2012 | 1020 | 0.060 |
Why?
|
| Boronic Acids | 1 | 2007 | 49 | 0.060 |
Why?
|
| Mutation, Missense | 1 | 2011 | 935 | 0.060 |
Why?
|
| Algorithms | 1 | 2013 | 1678 | 0.060 |
Why?
|
| Pyrazines | 1 | 2007 | 79 | 0.060 |
Why?
|
| Calcium | 1 | 2011 | 1034 | 0.060 |
Why?
|
| Liver Neoplasms | 1 | 1996 | 1402 | 0.060 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2025 | 31 | 0.060 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2025 | 69 | 0.060 |
Why?
|
| Recombination, Genetic | 1 | 2007 | 423 | 0.060 |
Why?
|
| Osteosarcoma | 1 | 2008 | 268 | 0.060 |
Why?
|
| Mad2 Proteins | 1 | 2004 | 7 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 2015 | 1547 | 0.050 |
Why?
|
| Logistic Models | 1 | 2009 | 1826 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 2 | 1996 | 980 | 0.050 |
Why?
|
| RNA-Binding Proteins | 1 | 2008 | 544 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 1996 | 411 | 0.050 |
Why?
|
| Bone Neoplasms | 1 | 2008 | 452 | 0.050 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2002 | 11 | 0.050 |
Why?
|
| Calcium-Binding Proteins | 1 | 2004 | 326 | 0.050 |
Why?
|
| Caspase Inhibitors | 1 | 2002 | 31 | 0.050 |
Why?
|
| Prostaglandins | 1 | 2002 | 36 | 0.050 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2002 | 122 | 0.050 |
Why?
|
| Etoposide | 1 | 2002 | 116 | 0.050 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 2002 | 4 | 0.050 |
Why?
|
| 5,8,11,14-Eicosatetraynoic Acid | 1 | 2002 | 2 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2002 | 299 | 0.050 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2002 | 59 | 0.050 |
Why?
|
| Caspases | 1 | 2002 | 157 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 1 | 2004 | 978 | 0.050 |
Why?
|
| Phenotype | 1 | 2011 | 4482 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 2002 | 585 | 0.040 |
Why?
|
| Testis | 2 | 2007 | 411 | 0.040 |
Why?
|
| Salmon | 3 | 1997 | 5 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 2004 | 771 | 0.040 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 1998 | 329 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2007 | 1619 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2019 | 49 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2019 | 65 | 0.040 |
Why?
|
| Gonadotropins, Pituitary | 1 | 1998 | 4 | 0.040 |
Why?
|
| Tissue Extracts | 1 | 1998 | 10 | 0.040 |
Why?
|
| Sequence Homology | 1 | 1998 | 58 | 0.030 |
Why?
|
| Lampreys | 1 | 1997 | 1 | 0.030 |
Why?
|
| Time Factors | 2 | 2000 | 6250 | 0.030 |
Why?
|
| Pituitary Gland | 1 | 1998 | 78 | 0.030 |
Why?
|
| Perciformes | 1 | 1997 | 10 | 0.030 |
Why?
|
| Hydroxyprogesterones | 1 | 1996 | 3 | 0.030 |
Why?
|
| Transforming Growth Factor alpha | 1 | 1996 | 27 | 0.030 |
Why?
|
| Gonadotropins | 1 | 1996 | 30 | 0.030 |
Why?
|
| Epidermal Growth Factor | 1 | 1996 | 116 | 0.030 |
Why?
|
| Thymidine | 1 | 1995 | 49 | 0.030 |
Why?
|
| Enzyme Induction | 1 | 2015 | 96 | 0.030 |
Why?
|
| Fishes | 1 | 1995 | 32 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2015 | 96 | 0.030 |
Why?
|
| Catfishes | 1 | 1994 | 1 | 0.030 |
Why?
|
| Diploidy | 1 | 2013 | 40 | 0.030 |
Why?
|
| Mammals | 1 | 1995 | 251 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2015 | 229 | 0.030 |
Why?
|
| Cell Division | 1 | 1995 | 717 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2013 | 153 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2000 | 1564 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2015 | 234 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2013 | 160 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2015 | 827 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 1079 | 0.020 |
Why?
|
| Thermodynamics | 1 | 1992 | 148 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2013 | 363 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2015 | 1215 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 1992 | 812 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2015 | 703 | 0.020 |
Why?
|
| DNA Mismatch Repair | 1 | 2009 | 45 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2009 | 239 | 0.020 |
Why?
|
| Genes, cdc | 1 | 2008 | 24 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2008 | 95 | 0.020 |
Why?
|
| Spermatocytes | 1 | 2007 | 23 | 0.020 |
Why?
|
| DNA, Cruciform | 1 | 2007 | 18 | 0.020 |
Why?
|
| I-kappa B Kinase | 1 | 2007 | 57 | 0.020 |
Why?
|
| Bortezomib | 1 | 2007 | 72 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2007 | 291 | 0.020 |
Why?
|
| Infertility | 1 | 2007 | 73 | 0.010 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2007 | 240 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2008 | 1055 | 0.010 |
Why?
|
| Temperature | 2 | 1997 | 288 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 789 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2007 | 448 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 2007 | 577 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2007 | 749 | 0.010 |
Why?
|
| Cell Membrane | 2 | 1997 | 451 | 0.010 |
Why?
|
| Sex Factors | 1 | 2007 | 1340 | 0.010 |
Why?
|
| Alleles | 1 | 2007 | 1671 | 0.010 |
Why?
|
| Pyrrolidonecarboxylic Acid | 1 | 1997 | 6 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 31326 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 1997 | 81 | 0.010 |
Why?
|
| Ovulation | 1 | 1997 | 105 | 0.010 |
Why?
|
| Reproduction | 1 | 1997 | 214 | 0.010 |
Why?
|
| Estradiol | 1 | 1997 | 478 | 0.010 |
Why?
|
| Chickens | 1 | 1994 | 269 | 0.010 |
Why?
|
| Infant | 1 | 2007 | 13306 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2007 | 15004 | 0.010 |
Why?
|
| Adolescent | 1 | 2007 | 20838 | 0.000 |
Why?
|
| Child | 1 | 2007 | 26199 | 0.000 |
Why?
|